Yarwood Jeremy, the Chief Scientific Officer of Neogen Corp, has reported ownership of 297 shares of common stock in the company. This filing is significant as it highlights the commitment to transparency in corporate governance and ownership structures.
Neogen Corp, identified by CIK 0000711377, operates in the in vitro and in vivo diagnostic substances sector. The company is based in Lansing, Michigan, and is recognized for its contributions to health and safety through innovative diagnostic solutions. The recent filing, dated October 21, 2026, is part of a series of disclosures aimed at maintaining accountability within the organization.
According to the filing, Yarwood's ownership is indirect, as the shares are held by his son. The filing states, "The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose." This statement underscores the importance of clarifying ownership details in corporate filings.
This update may affect various stakeholders, including investors, employees, and regulatory bodies, as it provides insight into the ownership dynamics at Neogen Corp. Transparency in such matters is crucial for maintaining trust and integrity in the corporate environment.
The filing does not say what happens next.